Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 46 | 0 | 11 | 0 | €114.70 | €149.74 | 30.546% |
| Alnylam Pharmace. | 46 | 0 | 8 | 0 | €234.40 | €271.88 | 15.990% |
| Tenet Healthcare | 42 | 0 | 4 | 0 | €149.00 | €154.91 | 3.968% |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €14.13 | €29.92 | 111.790% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €105.00 | €183.41 | 74.680% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | €43.71 | €56.72 | 29.768% |
| United Therapeutics | 27 | 1 | 5 | 1 | €328.10 | €341.51 | 4.087% |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | €51.00 | €84.74 | 66.165% |
| Icon plc | 24 | 0 | 0 | 0 | €289.40 | €326.21 | 12.720% |
| Halozyme Therapeutics Inc. | 23 | 0 | 5 | 0 | €57.58 | €56.00 | -2.747% |
| Merit Medical Systems | 22 | 0 | 3 | 0 | €86.00 | €90.45 | 5.179% |
| Exelixis Inc. | 21 | 0 | 3 | 0 | €23.23 | €26.01 | 11.952% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | €10.39 | €26.24 | 152.634% |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 1 | 0 | €21.26 | €55.13 | 159.332% |
| Alkermes plc | 17 | 2 | 0 | 0 | €25.40 | €35.01 | 37.847% |
| Molina Healthcare | 17 | 1 | 2 | 0 | €316.40 | €370.26 | 17.023% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €182.85 | €215.54 | 17.877% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €322.60 | €418.12 | 29.610% |
| CONMED Corp. | 15 | 2 | 4 | 0 | €63.00 | €98.42 | 56.219% |
| PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | €31.60 | €41.51 | 31.369% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | €176.75 | €247.61 | 40.089% |
| LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| Amedisys Inc. | 11 | 0 | 0 | 0 | €87.00 | €92.26 | 6.046% |